Altman Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-5,822
Closed -$1.06M – 88
2021
Q1
$1.06M Sell
5,822
-217
-4% -$50.3K 0.68% 62
2020
Q4
$1.21M Buy
6,039
+121
+2% +$24.6K 0.76% 55
2020
Q3
$1.3M Buy
5,918
+72
+1% +$15.2K 0.92% 49
2020
Q2
$1.12M Buy
5,846
+214
+4% +$37.5K 0.95% 48
2020
Q1
$873K Buy
+5,632
New +$655K 0.81% 56

Other funds holding TDOC

Altman Advisors's TDOC Position: Q2 2021 in Review

Altman Advisors sold out of Teladoc Health (TDOC) in Q2 2021, closing a stake of 5,822 shares — an estimated $1.06M sold.

Altman Advisors first reported a position in TDOC in Q1 2020 and held it in 5 quarters. The position peaked at $1.3M in Q3 2020. 829 funds tracked by Wall St. Rank hold TDOC as of Q2 2021.

  • Altman Advisors reported no remaining Teladoc Health position as of Q2 2021 after selling out during the quarter.
  • Altman Advisors sold 5,822 Teladoc Health shares in Q2 2021, an estimated $1.06M.
  • Altman Advisors first reported a position in Teladoc Health in Q1 2020 and held it in 5 quarters.
  • Altman Advisors's Teladoc Health position peaked at $1.3M in Q3 2020.
  • 829 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2021.

Based on Altman Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.